In brief
This umbrella review of 14 systematic reviews found consistent, including high-quality, evidence that cognitive stimulation therapy (CST) improves cognition in people with dementia, but evidence for its effects on mood, behavior, quality of life, and daily function was inconsistent and lower quality. Multi-component...
What this article is about
Quick Answer
This umbrella review of 14 systematic reviews found consistent, including high-quality, evidence that cognitive stimulation therapy (CST) improves cognition in people with dementia, but evidence for its effects on mood, behavior, quality of life, and daily function was inconsistent and lower quality. Multi-component CST delivered regularly appeared more effective than single-component or irregular programs.
Student takeaways
Key Takeaways
- Fourteen systematic reviews and meta-analyses on cognitive stimulation therapy (CST) for dementia were included in this umbrella review, most rated as moderate methodological quality on AMSTAR 2.
- Eleven reviews, with overall confidence ratings from low to high (including high-quality evidence), consistently reported that CST significantly improves cognition in people with dementia.
- Effects of CST on depression, behavioral symptoms, quality of life, and activities of daily living were inconsistent across reviews, with only low- to moderate-quality supporting evidence.
- Few studies reported effects of CST on language and communication, anxiety, or memory, leaving these outcomes without sufficient evidence to draw conclusions.
- Multi-component CST interventions were found to be more effective than single-component interventions and need to be delivered on a regular basis.
Student summary
Why This Research Matters
Dementia causes progressive cognitive decline that makes everyday activities harder to manage, and cognitive stimulation therapy (CST) is one of the most widely used non-drug interventions offered to people living with the condition. This 2023 paper, published in Experimental Gerontology by Cao and colleagues, is an umbrella review — a review of reviews. Instead of analyzing individual trials, the authors pulled together existing systematic reviews and meta-analyses on CST to see what the overall body of evidence actually shows, and how trustworthy that evidence is.
The team searched eight databases, including Cochrane Library, PubMed, CINAHL, Web of Science, and several Chinese-language databases (CNKI, Wanfang Data, CBMdisc, VIP), from each database's inception through December 31, 2022. They registered their protocol in advance with PROSPERO, the international registry for systematic review protocols, which adds transparency to the process. To judge how well-conducted each included review was, they used AMSTAR 2, a standardized 16-item checklist for appraising systematic reviews. Reviews that scored 9 or more points (moderate quality or better) were analyzed further using GRADE, a widely used framework for rating the certainty of evidence behind specific outcomes.
Fourteen systematic reviews and meta-analyses met the criteria for inclusion. Most were judged to be of moderate methodological quality on AMSTAR 2 — meaning the field has real reviews to draw on, but not many top-tier ones. The authors mapped out how CST was actually delivered across these studies: who provided it, how often sessions happened, how long programs ran, and where they took place (for example, care homes versus community settings). They also examined evidence across eight separate health outcomes: cognition, depression, behavioral and psychological symptoms, quality of life, activities of daily living (ADL), language and communication, anxiety, and memory.
The clearest and most consistent finding concerned cognition. Eleven of the included reviews, with overall confidence ratings ranging from low to high, consistently reported that CST significantly improves cognitive function in people with dementia, and some of this supporting evidence was rated high quality. This makes cognition the outcome with the strongest and most reproducible evidence base for CST.
The picture was much less clear for other outcomes. Effects on depression, behavioral symptoms, quality of life, and activities of daily living were inconsistent across the reviews, and the evidence behind them was rated only low to moderate quality — meaning we can't yet say with confidence whether CST reliably improves these areas. Language and communication, anxiety, and memory were each examined by only a handful of studies, so there simply isn't enough research volume yet to draw firm conclusions about CST's effect on these outcomes.
The authors concluded that CST is supported as an effective intervention for improving cognitive function specifically, and that multi-component CST programs (those combining several types of activities) tend to outperform single-component programs, provided they are delivered on a regular, ongoing basis. They also called for future systematic reviews in this area to be designed and reported using rigorous quality frameworks like AMSTAR 2, since inconsistent reporting quality was itself a limitation of the current evidence base.
For nursing students, this study is a useful example of evidence hierarchy in action: an umbrella review sits above individual trials and single systematic reviews, letting you see where the evidence is genuinely strong (cognition) versus where it is still emerging or mixed (mood, behavior, function, communication). It's a reminder that a popular, widely recommended therapy can have solid evidence for one outcome while still needing more research for others — and that reading the quality rating behind a claim matters just as much as the claim itself.
Source abstract
Study Overview
Background: Dementia is characterized by significant cognitive decline that results in disturbance of daily activities. Increasing number of meta-analyses has examined the efficacy of cognitive stimulation therapy (CST) for dementia. However, there is a lack of comprehensive reports that specifically discuss the strength of evidence to support CST for dementia. Purpose: This study aimed to summarize evidence regarding the efficacy of CST on people with dementia. Design: Umbrella review of systematic reviews and meta-analyses. Methods: We searched Cochrane Library, PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Data, China Biology Medicine disc (CBMdisc), and VIP databases from inception to December 31, 2022. The methodological quality of the identified studies was assessed using A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2). Studies scoring 9–12 (moderate quality) points or higher were further analyzed using Grades of Recommendations Assessment, Development and Evaluation (GRADE) principles. Results: A total of 14 systematic reviews and meta-analyses were included in the umbrella review. The methodological quality of most included reviews was rated as moderate according to AMSTAR 2 rating system. In these studies, we summarized the characteristics of the content, providers, frequency, period and setting of CST, and examined eight health outcomes related to CST, including cognition, depression, behavioral symptoms, quality of life (QoL), activities of daily living (ADL), language and communication, anxiety, and memory. Eleven studies with low to high rating of overall confidence (OC) consistently reported that CST could significantly improve cognition of people with dementia, including high-quality supporting evidence. However, the effect of CST on other health outcomes for people with dementia (e.g., depression, behavioral symptoms, QoL, ADL) is inconsistent, with low- to moderate-quality evidence ratings. Compared with the above results, few studies have reported the effects of CST on communication, anxiety, and memory for people with dementia. Conclusions: In the future, the design and reporting of systematic reviews and meta-analyses should incorporate high-quality research metrics in accordance with AMSTAR 2 criteria. The current review supports CST as an effective treatment for improving cognitive function in patients with dementia. Multi-component interventions are more effective than single-component interventions and need to be delivered regularly. Registration: The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) database (CRD42022364259).
Evidence appraisal
Main Findings
- Fourteen systematic reviews and meta-analyses on cognitive stimulation therapy (CST) for dementia were included in this umbrella review, most rated as moderate methodological quality on AMSTAR 2.
- Eleven reviews, with overall confidence ratings from low to high (including high-quality evidence), consistently reported that CST significantly improves cognition in people with dementia.
- Effects of CST on depression, behavioral symptoms, quality of life, and activities of daily living were inconsistent across reviews, with only low- to moderate-quality supporting evidence.
- Few studies reported effects of CST on language and communication, anxiety, or memory, leaving these outcomes without sufficient evidence to draw conclusions.
- Multi-component CST interventions were found to be more effective than single-component interventions and need to be delivered on a regular basis.
Practice transfer
Clinical Relevance
- Nurses and care teams can reasonably promote CST as an intervention specifically aimed at supporting cognitive function in people with dementia, since this is the outcome with the strongest supporting evidence.
- Clinical expectations for CST's effect on mood, behavioral symptoms, quality of life, and daily function should be set cautiously, given the inconsistent and lower-quality evidence for these outcomes.
- When designing or selecting a CST program, favoring multi-component activities delivered on a consistent, regular schedule aligns with the review's findings on what makes CST more effective.
- Because the evidence base for communication, anxiety, and memory outcomes is thin, nurses should avoid presenting CST as a proven treatment for these specific concerns and instead frame it as an area needing more research.
- Care teams appraising CST programs or research claims should check whether the underlying evidence has been quality-rated (e.g., via AMSTAR 2 or GRADE) rather than accepting broad claims of effectiveness at face value.
Faculty notes
Educational Relevance
This umbrella review by Cao et al. (2023), published in Experimental Gerontology, synthesizes evidence from systematic reviews and meta-analyses on cognitive stimulation therapy (CST) for people with dementia. Umbrella reviews sit at the top of the evidence hierarchy for intervention questions with a mature review literature, and this study is a good teaching case for how methodological rigor is assessed at that level, using AMSTAR 2 to appraise included reviews and GRADE to rate certainty of evidence for specific outcomes once a quality threshold (AMSTAR 2 score of 9+) was met.
Methodologically, the search strategy spanned eight databases — Cochrane Library, PubMed, CINAHL, Web of Science, and four Chinese-language databases (CNKI, Wanfang Data, CBMdisc, VIP) — searched from inception to December 31, 2022, with a PROSPERO-registered protocol (CRD42022364259). This breadth is a strength worth highlighting to students: including Chinese-language databases alongside the standard English-language sources reduces language bias, a common blind spot in reviews conducted solely in Western databases.
Fourteen systematic reviews/meta-analyses met inclusion criteria; most were rated moderate quality on AMSTAR 2, which is instructive in itself — it signals that even a mature-seeming intervention literature can lack a critical mass of high-quality reviews. The authors mapped intervention characteristics (content, provider, frequency, duration, setting) across the 14 reviews and evaluated evidence across eight outcome domains: cognition, depression, behavioral/psychological symptoms, quality of life, activities of daily living, language/communication, anxiety, and memory.
The central finding for classroom discussion is the split between strong and weak outcome evidence. Eleven reviews, with overall confidence ratings spanning low to high (including some high-quality evidence), consistently supported CST's benefit for cognition specifically. In contrast, evidence for depression, behavioral symptoms, quality of life, and ADL was inconsistent and only low-to-moderate quality, while language/communication, anxiety, and memory were addressed by too few studies to support any conclusion. This is a strong opportunity to discuss GRADE's distinction between the direction of an effect and the certainty behind it — students should be pushed to articulate why an intervention can be "supported" for one outcome and "unclear" for another within the very same evidence base.
The authors' practical conclusion — that multi-component CST delivered regularly outperforms single-component, irregular delivery — is a useful bridge to clinical application discussions: what does "multi-component" and "regular delivery" look like operationally in a long-term care or memory clinic setting, and what are the staffing and training implications of delivering CST with fidelity?
For faculty use, this paper works well in courses on evidence appraisal, gerontological nursing, and non-pharmacological dementia care. Suggested classroom exercises: (1) have students construct a GRADE evidence table for the eight outcome domains from the findings described; (2) have students critique why the authors limited GRADE analysis to only reviews scoring 9+ on AMSTAR 2, and what that threshold decision does to the review's inclusiveness versus rigor trade-off; (3) discuss the implications of 'inconsistent' behavioral-symptom evidence for a nurse deciding whether to recommend CST as an add-on for a resident's behavioral care plan versus purely for cognitive maintenance goals.
Critical appraisal
Limitations
- Most of the 14 included systematic reviews were rated only moderate quality on AMSTAR 2, limiting the overall strength of the conclusions that can be drawn.
- Evidence for outcomes other than cognition (depression, behavioral symptoms, quality of life, ADL) was inconsistent and rated low to moderate quality, so firm conclusions cannot be made for these outcomes.
- Language and communication, anxiety, and memory were assessed by very few of the included studies, meaning the evidence base for these outcomes is too sparse to draw conclusions.
Classroom use
Discussion Questions
- Why might an umbrella review be considered a stronger form of evidence than a single systematic review or meta-analysis, and what are its potential weaknesses?
- What does it mean that AMSTAR 2 rated most of the 14 included reviews as only 'moderate' quality, and how should that shape how confidently we interpret this umbrella review's conclusions?
- Why is the distinction between GRADE overall confidence ratings and AMSTAR 2 methodological quality ratings important when evaluating a body of evidence?
- Cognition showed the strongest evidence for improvement with CST, while depression, behavioral symptoms, QoL, and ADL showed inconsistent results. Why might an intervention affect one outcome domain more clearly than others?
- What practical steps could a long-term care facility take to implement CST as a 'multi-component intervention delivered regularly' rather than as an occasional single-activity program?
- How should a nurse communicate the strength (or lack) of evidence for CST's effect on mood and behavioral symptoms to a family asking whether it will help their loved one's agitation?
- Why did the authors include Chinese-language databases (CNKI, Wanfang Data, CBMdisc, VIP) alongside typical English-language databases, and what bias might this help address?
- What further research would be needed before nurses could confidently recommend CST specifically for improving communication, anxiety, or memory in dementia care?
- How does registering a review protocol in PROSPERO before conducting the review (as this study did) support the credibility of its findings?
- If you were designing a CST program for a memory care unit, what elements from this review's findings (multi-component design, regular delivery, provider training) would you prioritize, and why?
Knowledge check
Quiz
1. What type of review is this study?
- A randomized controlled trial
- An umbrella review of systematic reviews and meta-analyses
- A single systematic review of primary studies
- A case-control study
Rationale: The abstract states the study design is 'Umbrella review of systematic reviews and meta-analyses.'
2. Which tool did the authors use to assess the methodological quality of the included reviews?
- PRISMA checklist
- Cochrane Risk of Bias tool
- AMSTAR 2
- Newcastle-Ottawa Scale
Rationale: The abstract states: 'The methodological quality of the identified studies was assessed using A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR 2).'
3. How many systematic reviews and meta-analyses were included in this umbrella review?
- 8
- 11
- 14
- 20
Rationale: The abstract states: 'A total of 14 systematic reviews and meta-analyses were included in the umbrella review.'
4. For which health outcome did the umbrella review find the most consistent, high-quality supporting evidence for CST's benefit?
- Anxiety
- Cognition
- Language and communication
- Memory
Rationale: The abstract states 11 reviews 'consistently reported that CST could significantly improve cognition of people with dementia, including high-quality supporting evidence.'
5. How did the evidence for CST's effect on depression, behavioral symptoms, quality of life, and ADL compare to the evidence for cognition?
- It was equally strong and consistent
- It was inconsistent, with low- to moderate-quality evidence
- There was no evidence at all for these outcomes
- It showed CST clearly worsens these outcomes
Rationale: The abstract states the effect of CST on these outcomes 'is inconsistent, with low- to moderate-quality evidence ratings.'
6. Which framework did the authors use to rate the certainty of evidence for reviews scoring 9 or higher on AMSTAR 2?
- GRADE
- ROBIS
- CASP
- SIGN
Rationale: The abstract states studies scoring 9-12 or higher 'were further analyzed using Grades of Recommendations Assessment, Development and Evaluation (GRADE) principles.'
7. Which outcomes had the fewest studies reporting on CST's effects, according to the review?
- Cognition and ADL
- Depression and quality of life
- Communication, anxiety, and memory
- Behavioral symptoms and cognition
Rationale: The abstract states: 'few studies have reported the effects of CST on communication, anxiety, and memory for people with dementia.'
8. According to the authors' conclusion, which type of CST intervention is more effective?
- Single-component interventions delivered occasionally
- Multi-component interventions delivered regularly
- Interventions delivered only by family caregivers
- Interventions lasting less than one week
Rationale: The abstract states: 'Multi-component interventions are more effective than single-component interventions and need to be delivered regularly.'
9. Where was this review's protocol registered before it was conducted?
- ClinicalTrials.gov
- PROSPERO
- Cochrane Central Register
- ISRCTN registry
Rationale: The abstract states: 'The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) database (CRD42022364259).'
10. What did most of the 14 included reviews score on AMSTAR 2?
- Critically low quality
- Moderate quality
- High quality with no concerns
- They were not rated
Rationale: The abstract states: 'The methodological quality of most included reviews was rated as moderate according to AMSTAR 2 rating system.'
Study cards
Flashcards
What is cognitive stimulation therapy (CST)?
A non-pharmacological intervention that engages people with dementia in structured activities aimed at stimulating cognitive function.
What type of review design did Cao et al. (2023) use?
An umbrella review of systematic reviews and meta-analyses.
How many systematic reviews and meta-analyses were included in this umbrella review?
14.
What tool did the authors use to assess the methodological quality of included reviews?
AMSTAR 2 (A Measurement Tool to Assess Systematic Reviews 2).
What framework did the authors use to rate certainty of evidence for higher-quality reviews?
GRADE (Grades of Recommendations Assessment, Development and Evaluation).
What AMSTAR 2 score threshold did reviews need to reach for further GRADE analysis?
9 to 12 points, corresponding to moderate quality or higher.
How many health outcomes did the review examine in relation to CST?
Eight: cognition, depression, behavioral symptoms, quality of life, activities of daily living, language and communication, anxiety, and memory.
Which outcome had the strongest, most consistent evidence supporting CST's benefit?
Cognition.
How many reviews consistently reported CST significantly improves cognition?
Eleven reviews, with overall confidence ratings ranging from low to high, including some high-quality evidence.
How was the evidence for CST's effect on depression, behavioral symptoms, QoL, and ADL described?
Inconsistent, with only low- to moderate-quality evidence ratings.
Which three outcomes had too few studies to draw firm conclusions?
Language and communication, anxiety, and memory.
What did the authors conclude about multi-component versus single-component CST interventions?
Multi-component interventions are more effective than single-component interventions and need to be delivered regularly.
In which journal and year was this umbrella review published?
Experimental Gerontology, 2023.
Where was the review's protocol registered, and what is its registration number?
PROSPERO, registration number CRD42022364259.
What time period did the literature search cover?
From each database's inception through December 31, 2022.
Name at least four databases searched in this umbrella review.
Cochrane Library, PubMed, CINAHL, Web of Science (also CNKI, Wanfang Data, CBMdisc, and VIP).
Why is it notable that this review searched Chinese-language databases as well as English-language ones?
It reduces language bias by capturing relevant studies that English-only searches might miss.
What did the authors recommend for future systematic reviews and meta-analyses on this topic?
That future reviews incorporate high-quality research metrics in accordance with AMSTAR 2 criteria.
What overall conclusion did the authors reach about CST for cognitive function?
CST is supported as an effective treatment for improving cognitive function in patients with dementia.
Why is it important for nurses to distinguish which outcomes CST evidence supports versus which remain unclear?
So they can set realistic expectations with patients and families, promoting CST confidently for cognition while being cautious about claims for mood, behavior, function, and other less-studied outcomes.
Search-ready answers
Frequently asked questions
What is cognitive stimulation therapy (CST) and why is it used in dementia care?
CST is a structured, non-drug intervention that engages people with dementia in activities designed to stimulate thinking, memory, and language, aiming to support cognitive function as part of overall dementia care.
Does research support cognitive stimulation therapy for dementia?
According to this 2023 umbrella review of 14 systematic reviews and meta-analyses, there is consistent evidence, including some high-quality evidence, that CST significantly improves cognition in people with dementia.
Does CST help with behavioral symptoms or mood in dementia?
The evidence is inconsistent. The review found only low- to moderate-quality evidence regarding CST's effects on depression, behavioral symptoms, quality of life, and activities of daily living.
Is CST more effective than other dementia interventions?
This review did not directly compare CST to other interventions; it focused on summarizing the quality and consistency of existing evidence specifically for CST.
What is an umbrella review and how does it differ from a systematic review?
An umbrella review synthesizes findings from multiple existing systematic reviews and meta-analyses on a topic, rather than analyzing individual primary studies, giving a higher-level summary of the overall evidence base.
How was the quality of the studies in this review assessed?
The authors used AMSTAR 2 to rate the methodological quality of each included systematic review, and GRADE to assess the certainty of evidence for reviews meeting a moderate-quality threshold.
How many studies were included in this umbrella review on CST for dementia?
Fourteen systematic reviews and meta-analyses were included.
What kind of CST program works best according to this research?
The authors concluded that multi-component CST interventions, delivered on a regular basis, are more effective than single-component or irregularly delivered programs.
What are the main limitations of the current evidence on CST for dementia?
Most included reviews were only moderate quality on AMSTAR 2, evidence for outcomes beyond cognition was inconsistent and low-to-moderate quality, and very few studies addressed communication, anxiety, or memory outcomes.
Where was this study's review protocol registered?
The protocol was registered in advance with PROSPERO, the International Prospective Register of Systematic Reviews, under registration number CRD42022364259.